THE NEED FOR CONTINUOUS CARE

Between visits. Before symptoms. From home.

Milnura is developing Floura, a non-invasive approach to at-home preeclampsia screening, designed with the weeks between prenatal visits in mind.

Partner with us Our approach
Abstract graphic representing at-home prenatal screening.
Floura
Non-invasive
Informed by the field
THE GAP

Preeclampsia doesn't keep a schedule.

Prenatal care happens at scheduled appointments, but pregnancy-related changes can occur between visits. Preeclampsia is a serious pregnancy complication that can develop with few noticeable symptoms. Milnura is exploring how screening approaches might extend beyond the clinic and into the time between appointments.

OUR APPROACH

What we're building toward

Milnura is exploring new approaches to preeclampsia screening, designed to fit the realities of everyday life between prenatal visits.

Non-invasive

Exploring an approach that does not rely on needles.

At home

Designed around the possibility of screening between prenatal visits, outside the clinic.

Multimodal

Exploring breath and urine biomarkers together rather than focusing on a single signal.

Informed by the field

Shaped by ongoing conversations with clinicians, researchers, nurses, midwives, doulas, and mothers.

Floura is in early development. Its design and intended use may evolve as research progresses.

Abstract graphic representing at-home prenatal screening.
WHO WE ARE

An early-stage company with a focused mission.

Milnura is exploring new approaches to preeclampsia screening, with a focus on the weeks between prenatal appointments. We're beginning with a serious complication of pregnancy and asking how screening could be designed to better fit the realities of everyday life.

Learn more about us →

Help shape what comes next.

We're connecting with clinicians, researchers, advisors, and funders who share an interest in advancing maternal health. If our work aligns with yours, we'd welcome a conversation.

Get in touch Our approach